When treated early, Stage 1 lung cancer patients have a five-year survival rate of above 70 per cent. Read more at straitstimes.com. Read more at straitstimes.com.

PSA is a validated FDA-recognized clinical endpoint in assessing prostate cancer treatment response; Telomir-1 lowered PSA ...

Genprex, Inc. ("Genprex" or the "Company") (NASDAQ: GNPX), a clinical-stage gene therapy company focused on developing ...

New artificial intelligence technology is helping diagnose the U.S.’s most deadly cancer sooner, greatly improving the ...

The Food and Drug Administration (FDA) granted traditional approval to Imdelltra (tarlatamab-dlle) for adult patients with ...

Researchers at Northwestern Medicine found that 65% of their lung cancer patients weren't eligible for screening. They were ...

Breast cancer may be more treatable than many other cancers, however, even their treatability depends on how early they are ...

Giredestrant significantly improves IDFS in ER-positive, HER2-negative early-stage breast cancer, surpassing standard ...

Traditionally, lung cancer is associated with older patients, specifically men who smoked. But doctors say that's beginning ...

The Food and Drug Administration (FDA) has granted traditional approval to Imdelltra ® (tarlatamab-dlle) for the treatment of adults with extensive stage small cell lung cancer (ES-SCLC) with disease ...

A cohort study links preexisting diabetes to poorer pancreatic cancer survival, but adulthood weight and exercise habits show ...

During day 1 of BravoCon 2025, Teddi Mellencamp tells PEOPLE how she's feeling about being at the event shortly after ...